Approved Indication:
- pulmonary arterial hypertension (WHO group 1) to improve exercise ability
- pulmonary hypertension associated with interstitial lung disease (PH-ILD, WHO group 3) to improve exercise ability
Conditions:
- Pulmonary Arterial Hypertension (PAH)
- Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)